Clinical trial
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of…
NCT00073021 · Warner Chilcott, Industry · Completed
Key facts
| NCT number | NCT00073021 |
|---|---|
| Title | Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis |
| Official title | A Double-Blind, Randomized, 6-Week, Parallel-Group Design Clinical Trial to Assess Safety and Efficacy of Asacol 4.8 g/Day (800 mg Tablet) Versus Asacol 2.4 g/Day (400 mg Tablet) for the Treatment of Moderately Active Ulcerative Colitis |
| Lead sponsor | Warner Chilcott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | Asacol 800 mg (mesalamine), Asacol 400 mg (mesalamine) |
| Enrollment | 386 |
| Start date | Sep 1, 2000 |
| Primary completion | Sep 1, 2003 |
| Completion | Sep 1, 2003 |
| First posted | Nov 17, 2003 |
| Last update posted | Jun 29, 2015 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: